GALNT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.096200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.223810E-01
Normal-vs-Stage2
1.143000E-01
Normal-vs-Stage3
1.725610E-01
Normal-vs-Stage4
4.373400E-01
Stage1-vs-Stage2
4.276800E-01
Stage1-vs-Stage3
9.735800E-01
Stage1-vs-Stage4
3.812400E-01
Stage2-vs-Stage3
4.909000E-01
Stage2-vs-Stage4
6.743600E-01
Stage3-vs-Stage4
4.144000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.978100E-02
Normal-vs-AfricanAmerican
4.009800E-01
Normal-vs-Asian
4.634200E-02
Caucasian-vs-AfricanAmerican
7.047400E-01
Caucasian-vs-Asian
4.525600E-01
AfricanAmerican-vs-Asian
2.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.005800E-01
Normal-vs-Female
9.587700E-02
Male-vs-Female
6.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.136240E-01
Normal-vs-Age(41-60Yrs)
3.013600E-01
Normal-vs-Age(61-80Yrs)
4.994000E-02
Normal-vs-Age(81-100Yrs)
6.204300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.000400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.733600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.618980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.858600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.983210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.710100E-02
Normal-vs-Daily Drinker
1.447500E-02
Normal-vs-Weekly Drinker
2.949200E-01
Normal-vs-Occasional Drinker
3.874400E-01
Normal-vs-Social Drinker
5.419600E-01
Non Drinker-vs-Daily Drinker
6.470600E-01
Non Drinker-vs-Weekly Drinker
3.776000E-01
Non Drinker-vs-Occasional Drinker
4.536300E-02
Non Drinker-vs-Social Drinker
7.047500E-02
Daily Drinker-vs-Weekly Drinker
2.210800E-01
Daily Drinker-vs-Occasional Drinker
2.598300E-02
Daily Drinker-vs-Social Drinker
4.188400E-02
Weekly Drinker-vs-Occasional Drinker
1.793970E-01
Weekly Drinker-vs-Social Drinker
1.608160E-01
Occasional Drinker-vs-Social Drinker
7.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.197600E-01
Normal-vs-Grade 2
1.806400E-01
Normal-vs-Grade 3
1.954970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.995600E-01
Grade 1-vs-Grade 3
3.299400E-01
Grade 1-vs-Grade 4
3.197600E-01
Grade 2-vs-Grade 3
4.275600E-01
Grade 2-vs-Grade 4
1.806400E-01
Grade 3-vs-Grade 4
1.954970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.726100E-02
Normal-vs-NonDiabetic
7.416000E-02
Diabetic-vs-NonDiabetic
1.552220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.164600E-01
Normal-vs-NoPancreatitis
8.640100E-02
Pancreatitis-vs-NoPancreatitis
5.480100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.573800E-02
Normal-vs-N1
1.053000E-01
N0-vs-N1
3.856600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.542610E-01
Normal-vs-TP53-NonMutant
1.288820E-01
TP53-Mutant-vs-TP53-NonMutant
8.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
